The European Medicines Agency (EMA) has shared guidance on how applicants can declare whether a submission falls under the scope of the Health Technology Assessment Regulation (HTAR) and is subject to ...
The European Medicines Agency (EMA) has opened a new consultation on a draft guideline that would revise a set of biosimilar guidelines first put in place six years ago. The guideline, On non-clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results